Immunovant Crumbles After Roivant Sweeps Out Its C-Suite, Unveils Strategic Shift
Roivant Sciences is making serious changes to subsidiary Immunovant, announcing Monday a series of C-suite changes and new disease targets. The post Immunovant Crumbles After Roivant Sweeps Out Its C-Suite, Unveils Strategic Shift appeared first on Investor's Business Daily.
Roivant Sciences is making serious changes to subsidiary Immunovant, announcing Monday a series of C-suite changes and new disease targets.
The post Immunovant Crumbles After Roivant Sweeps Out Its C-Suite, Unveils Strategic Shift appeared first on Investor's Business Daily.
iShook Opinion
"iShook Opinion" by Beni E Rachmanov, CEO & Founder of iShook. Explore captivating perspectives on entertainment, lifestyle, and sports at ishookdaily.com. Your go-to for engaging insights.
